Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LEMD2 - Sunitinib effect on renal cancer xenograft tumors
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LEMD2 - Peptidyl-prolyl cis/trans isomerase Pin1 deficiency effect on prostate cancer cells
LEMD2 - Parkin expression in parkin-deficient U87MG glioma cells
LEMD2 - HIV envelope protein gp120 effect on activated B cells from healthy donors: time course
LEMD2 - Insulin-Producing Cells generated from dedifferentiated pancreatic islet cells expanded in vitro
LEMD2 - Renal clear cell carcinoma-thyroid hormone receptor mutants: HepG3 cell line
LEMD2 - Lymphoblastoid cell response to low-dose cadmium exposure in vitro
LEMD2 - Interleukin-17A effect on primary airway smooth muscle cells from asthmatics
LEMD2 - SMRT depleted breast cancer cell line response to estradiol: time course
LEMD2 - Mutant p53 depletion effect on MDA-468.shp53 breast tumor cell line
LEMD2 - Transcription factor c-MYC intron binding protein 1 overexpression effect on embryonic kidney cells
LEMD2 - Triple negative breast cancer
LEMD2 - Oligooxopiperazine effect on hypoxic alveolar adenocarcinoma cell line
LEMD2 - Fibroblast response to coculture with basal breast cancer cells
LEMD2 - Cultivated amniotic membrane expanded limbal epithelium
LEMD2 - Epidermal growth factor effect on HER2-overexpressing mammary epithelial MCF10A cells: time course
LEMD2 - First, second and third trimester pregnancy: maternal cell-free plasma
LEMD2 - Obstructive sleep apnea response to continuous positive airway pressure treatment: leukocytes
LEMD2 - Xenograft ovarian tumor response to anti-cancer therapeutic MT19: time course
LEMD2 - Turner syndrome amniocyte derived-induced pluripotent stem cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on